Novartis Investigative Site — Anchorage, Alaska

Novartis Investigative Site is a clinical research site located in Anchorage, Alaska, United States 99508.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 8 clinical trials.

Therapeutic areas: Heart Failure With Reduced Ejection Fraction, Atherosclerosis, Non-Hodgkin's Lymphoma.

Sponsors: Novartis Pharmaceuticals, Mylan Inc., Novartis.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 8 clinical trials on record. Their work covers Heart Failure With Reduced Ejection Fraction, Atherosclerosis, Non-Hodgkin's Lymphoma.

Is Novartis Investigative Site accredited by Crixeo Health?

Yes — Novartis Investigative Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.